Gender-related issues in the female inflammatory bowel disease patient

Expert Review of Gastroenterology and Hepatology

Volumn 3, Issue 2, 2009, Pages 145-154

  Okoro, Ngozi Ivunanya ^a   Kane, Sunanda V ^a  

^a MAYO CLINIC   (United States)

Author keywords

Crohn's disease; Fertility; Menstruation; Pregnancy; Ulcerative colitis

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; MERCAPTOPURINE; ORAL CONTRACEPTIVE AGENT; SALAZOSULFAPYRIDINE;

BREAST FEEDING; CANCER RISK; CANCER SCREENING; CONTRACEPTION; CROHN DISEASE; DEFECATION HABIT; DIARRHEA; DISEASE ACTIVITY; DISEASE PREDISPOSITION; DRUG CONTRAINDICATION; DRUG SAFETY; ENTERITIS; FEMALE; FEMALE FERTILITY; GASTROINTESTINAL SYMPTOM; GENDER BIAS; HORMONE RESPONSE; HUMAN; LOW DRUG DOSE; MENARCHE; MENSTRUAL CYCLE; ONSET AGE; PAPANICOLAOU TEST; PREGNANCY; PREVALENCE; REVIEW; RISK FACTOR; SEX DIFFERENCE; ULCERATIVE COLITIS; UTERINE CERVIX CANCER; FERTILITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SEXUAL DEVELOPMENT; UTERINE CERVIX TUMOR;

FEMALE; FERTILITY; HUMANS; INFLAMMATORY BOWEL DISEASES; MENSTRUAL CYCLE; PREGNANCY; RISK FACTORS; SEX CHARACTERISTICS; UTERINE CERVICAL NEOPLASMS;

EID: 67649888813     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.09.1     Document Type: Review

References (68)

1. Trachter AB, Rogers AI, Leiblum SR. Inflammatory bowel disease in women: impact on relationship and sexual health. Inflamm. Bowel Dis. 8(6), 413-421 (2002).
2. Kappelman MD, Rifas-Shiman SL, Klkeinman K et al. The prevelance and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin. Gastroenterol. Hepatol. 5, 1424-1429 (2007).
3. Silverstein MD, Lashner BA, Hanauer SB, Evans AA, Kirsner JB. Cigarette smoking in Crohn's disease. Am. J. Gastroenterol. 84, 31-33 (1989).
4. Maunder R, Toner B, de Rooy E, Moskovitz D. Influence of sex and disease on illness-related concerns in inflammatory bowel disease. Can. J. Gastroenterol. 13(9), 728-732 (1999).
5. Counihan TC, Roberts PL, Schoetz DJ Jr, Coller JA, Murray JJ, Veidenheimer MC. Fertility and sexual and gynecologic function after ileal pouch - anal anastomosis. Dis. Colon Rectum 37, 1126-1129 (1994).
6. Kane SV, Sable K, Hanauer SB. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am. J. Gastroenterol. 93, 1867-1872 (1998).
7. Timonen S, Procrope B. The premenstrual syndrome: frequency and association of symptoms. Ann. Chir. Gyn. Fenn. 62, 108-116 (1973).
8. Rees WD, Rhodes J. Altered bowel habit and menstruation. Lancet 1(7982), 475 (1976).
9. Weber AM, Ziegler C, Belinson JL et al. Gynecologic history of women with inflammatory bowel disease. Obstet. Gyncol. 86, 843-847 (1995).
10. Jaffe B, Prostaglandins and serotonin in diarrheogenic syndromes. In: Gastrointestinal Hormones and the Pathology of the Digestive System. Grossman M (Ed.). Plenum Press, NY, USA (1978).
11. Erkan P, Ulku D, Canan A et al. Pattern of gastrointestinal and psychosomatic symptoms across the menstrual cycle in women with inflammatory bowel disease. Turk. J. Gastroenterol. 14(4), 250-256 (2003).
12. Lichtarowicz A, Norman C, Calcraft B et al. A study of the menopause, smoking, and contraception in women with Crohn's disease. Q. J. Med. 72, 623-631 (1989).
13. Bernard VB, Eheman CR, Lawson HW et al. Cervical screening in the National Breast and Cervical Cancer Early Detection Program 1995-2001. Obstet. Gynecol. 103, 564-571 (2004).
14. Edelman M, Fox AS, Alderman EM et al. Cervical Papanicolau smear abnormalities in inner city Bronx adolescents: prevalence, progression, and immune modifiers. Cancer 87, 184-189 (1999).
15. Tam LS, Chan AY, Chun PK et al. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. Arthritis Rheum. 50, 3619-3625 (2004).
16. Bhatia J, Bratcher J, Korelitz B et al. Abnormalities of uterine cervix in women with inflammatory bowel disease. World J. Gastroenterol. 12(38), 6167-6171 (2006).
17. Kane S, Khatibi B, Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am. J. Gastroenterol. 103, 631-636 (2008).
18. Hutfless S, Fireman B, Kane S et al. Screening differences and risks of cervical cancer in inflammatory bowel disease. Aliment. Pharmacol. Ther. 28, 598-605 (2008).
19. Lees C, Critchley J, Chee N et al. Cervical dysplasia and inflammatory bowel disease: no effect of disease status or immunosuppressants on analysis of 2,199 smear records. Gastroenterology 134(4 Suppl. 1), A967 (2008).
20. Singh H, Demers A, Nugent A et al. Risk of cervical abnormalities in women with IBD: a population-based nested case - control study. Gastroenterology 134(4 Suppl. 1), A965 (2008).
21. Lyles T, Oster R, Gutierrez A. Prevalence of abnormal pap smears in patients with inflammatory bowel disease on immune modulator therapy. Gastroenterology 134(4 Suppl. 1), A966 (2008).
22. Miller JP. Inflammatory bowel disease in pregnancy: a review. J. R. Soc. Med. 79, 221-225 (1986).
23. Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn's disease: a case - control study by European collaborative group. Gut 27, 821-825 (1986).
24. Fonager K, Sorensen HT, Olsen J et al. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am. J. Gastroenterol. 93, 2426-2430 (1998).
25. Alstead E. Fertility and pregnancy in inflammatory bowel disease. World J. Gastroenterol. 7(4), 455-459 (2001).
26. Waljee A, Waljee J, Morris A, Higgin PD. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut 55, 1575-1580 (2006).
27. Mortier PE, Gambiez L, Karoui M et al. Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis. Gastroenterol. Clin. Biol. 30, 594-597 (2006).
28. O'Morian C, Smethurst P, Dore CJ et al. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 25, 1078-1084 (1984).
29. Burnell D, Mayberry J, Calcraft BJ et al. Male fertility in Crohn's disease. Postgrad. Med. J. 62, 269-272 (1986).
30. Mahadeven U, Terdiman JP, Aron J et al. Infliximab and semen quality in men with inflammatory bowel disease. Inflamm. Bowel Dis. 11(4), 359-359 (2005).
31. Orholm M, Fonager K, and Sorensen HT. Risk of ulcerative colitis and Crohn's disease among offspring of patients with chronic inflammatory bowel disease. Am. J. Gastroenterol. 94, 3236-3238 (1999).
32. Yang H, McElree C, Roth MP et al. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 34, 517-524 (1993).
33. Hanker JP. Gastrointestinal disease and oral contraception. Am. J. Obstet. Gynecol. 163, 2204-2207 (1990).
34. Cosnes J, Carbonnel F, Carrat F et al. Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut 45, 218-222 (1999).
35. Cornish J, Emile T, Simillis C et al. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am. J. Gastroenterol. 103, 2394-2400 (2008).
36. Timmer A, Sutherland LR, Martin F. Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology 114, 1143-1150 (1998).
37. Wright JP. Factors influencing first relapse in patients with Crohn's disease. J. Clin. Gastroenterol. 15, 12-16 (1992).
38. Sutherland LR, Ramcharan S, Bryant H. et al. Effect of Oral contraceptive use on reoperation following surgery for Crohn's disease. Dig. Dis. Sci. 37, 1377-1382 (1992).
39. Cornish J, Tan E, Teoh T et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 56, 830-837 (2007).
40. Moser MA, Okun NB, Mayes DC et al. Crohn's disease, pregnancy, and birth weight. Am. J. Gastroenterol. 95, 1021-1026 (2000).
41. Porter RJ, Stirrat GM. The effects of inflammatory bowel disease on pregnancy: a case - controlled retrospective analysis. Br. J. Obstet. Gynaecol. 93, 1124-1131 (1986).
42. Ilnyckyj A, Blanchard JF, Rawsthorne P et al. Perianal Crohn's disease and pregnancy: role of the mode of delivery. Am. J. Gastroenterol. 94, 3274-3278 (1999).
43. Riis L, Vind I, Politi P et al. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am. J. Gastroenterol. 101, 1539-1545 (2006).
44. Castiglione F, Pignata S, Morace F et al. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital. J. Gastroenterol. 28, 199-204 (1996).
45. Nwokolo C, Tan WC, Andrews HA et al. Surgical resections in parous patients with distal ileal and colonic Crohn's disease. Gut 35, 220-223 (1994).
46. Cappell MS, Colon VJ, Sidhom OA. A study at 10 medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups. Dig. Dis. Sci. 41, 2353-2361 (1996).
47. Sachar D. Exposure to mesalamine during pregnancy increased preterm deliveries (but not birth defects) and decreased birth weight. Gut 43, 316 (1998).
48. Mahadevan U, Sandborn WJ, Li DK et al. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from northern California. Gastroenterology 133, 1106-1112 (2007).
49. Diav-Citrin O, Park YH, Veerasuntharam G. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 114, 23-28 (1998).
50. Marteau P, Tennenbaum R, Elefant E. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment. Pharmacol. Ther. 12, 1101-1108 (1998).
51. McKay DB, Josephson AM. Pregnancy in recipients of solid organs - effects on mother and child. N. Engl. J. Med. 354(12), 1281-1293 (2006).
52. Francella A, Dayan A, Bodian C et al. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 124(1), 9-17 (2003).
53. De Boer NK, Jarbandhan SV, Peer de Graff MS et al. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am. J. Gastroenterol. 101, 1390-1392 (2006).
54. Norgard B, Pedersen L, Christensen LA, Sorensen HT. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am. J. Gastroenterol. 102, 1406-1413 (2007).
55. Langagergaard V, Pedersen L, Gisium M et al. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: a Danish nationwide cohort study. Aliment. Pharmacol. Ther. 25, 73-81 (2007).
56. Mahadevan U, Kane S, Sandborn WJ et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment. Pharmacol. Ther. 21(6), 733-738 (2005).
57. Vasiliauskas EA, Chruch JA, Silverman N et al. Case report: evidence for transplacental transfer of maternally administered infliximab tc the newborn. Clin. Gastroenterol. Hepatol. 4, 1255-1258 (2006).
58. Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut 54(6), 890 (2005).
59. Mishkin D, van Deinse W, Becker J, Farraye FA. Successful use of adalimumab for Crohn's disease in pregnancy. Inflamm. Bowel Dis. 12(8), 827-828 (2006).
60. Mahadevan U, Nazareth M, Cristiano L et al. Natalizumab use during pregnancy. Am. J. Gastroenterol. 103(4 Suppl. 1), A1150 (2008).
61. Rosa FW, Baum C, Shaw M. Pregnancy outcdmes after first-trimester vaginitis drug therapy. Obstet. Gynecol. 69, 751-755 (1987).
62. Lepisto A, Sarna S, Tiitinen A, Jarvinen HJ. Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis. Br. J. Surg. 94, 478-482 (2007).
63. Cornish J, Tan E, Teare J et al. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy, and delivery: a systematic review. Dis. Colon Rectum 50, 1128-1138 (2007).
64. Tiainen J, Matikainen M, Hiltunen KM. Ileal J-pouch - anal anastomosis, sexual dysfunction, and fertility. Scand. J. Gastroenterol. 34, 185-188 (1999).
65. Damgaard B, Wettergren A, Kirkegaard P. Social and sexual function following ileal pouch-anal anastomosis. Dis. Colon Rectum 38, 286-289 (1995).
66. Bambrick M, Fazio VW, Hull TL, Pucel G. Sexual function following restorative proctocolectomy in women. Dis. Colon Rectum 39, 610-614 (1996).
67. Metcalf AM, Dozois RR, Kelly KA. Sexual function in women after proctocolectomy. Ann. Surg. 204(6), 624-628 (1986).
68. Kane S, Reddy D. Hormone replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. Am. J. Gastroenterol. 103, 1193-1196 (2008).